Association of Anemia with Parathyroid Hormone Levels and Other Factors in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Cross-Sectional, Real-World Data Study in Pakistan
End-stage renal disease (ESRD) patients are mostly managed with maintenance hemodialysis (MHD). ESRD patients on MHD also present with many complications, such as anemia, hyperparathyroidism, and hepatitis prevalence. This study depicts the real-world scenario of anemia among MHD and end-stage renal...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | International Journal of Clinical Practice |
| Online Access: | http://dx.doi.org/10.1155/2023/7418857 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849701204547862528 |
|---|---|
| author | Humera Bukhari Aneeqa Ahmad Amna Noorin Aimal Khan Mehwish Mushtaq Aamir Naeem Muhammad Rashid Iqbal Faiza Naureen Yasar Shah Ahad Qayyum Syed Munib Amer Azhar Farman Ullah Faris Farooq Saeed Khan |
| author_facet | Humera Bukhari Aneeqa Ahmad Amna Noorin Aimal Khan Mehwish Mushtaq Aamir Naeem Muhammad Rashid Iqbal Faiza Naureen Yasar Shah Ahad Qayyum Syed Munib Amer Azhar Farman Ullah Faris Farooq Saeed Khan |
| author_sort | Humera Bukhari |
| collection | DOAJ |
| description | End-stage renal disease (ESRD) patients are mostly managed with maintenance hemodialysis (MHD). ESRD patients on MHD also present with many complications, such as anemia, hyperparathyroidism, and hepatitis prevalence. This study depicts the real-world scenario of anemia among MHD and end-stage renal disease patients in the Pakistani population. A retrospective, multicentric, and real-world data analytical study was conducted at 4 dialysis centers in Pakistan. The study had a sample size of n = 342 patients on maintenance hemodialysis. The data were gathered from the medical records of patients. Data analysis was performed using STATA Version 16. Statistical significance was gauged at a 0.05 level of significance. According to our results, the mean age of the patients was 45 (±15) years. Most of the patients were male (n = 234, 68.4%), whereas 58.1% of the patients were maintained on twice-weekly hemodialysis. The most commonly reported comorbidities were hypertension and diabetes mellitus. The frequency of dialysis (P < 0.01) and comorbidities (P = 0.009) had a significant association with anemia in MHD patients. The majority of the patients had hyperparathyroidism (52%) with anemia. Upon performing binary logistic regression, multivariate analysis displayed a similar odds value for having anemia in patients with every additional month in the duration of hemodialysis (OR 1.01, P = 0.001), the odds of anemic patients having a positive antihepatitis-C antibody (OR 2.22, P = 0.013), and the odds of having anemia in patients in the age category below 45 years (OR 1.93, P = 0.013). In conclusion, the study results depict that every additional month in the duration of hemodialysis, age (<45 years), and positive anti-HCV antibody status, these variables were more likely to have anemia in our study MHD patients. While in our final multivariate model, no statistically significant association was observed between hyperparathyroidism and anemia. |
| format | Article |
| id | doaj-art-67443d3228124cfb921aeafd70f8bfd3 |
| institution | DOAJ |
| issn | 1742-1241 |
| language | English |
| publishDate | 2023-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Clinical Practice |
| spelling | doaj-art-67443d3228124cfb921aeafd70f8bfd32025-08-20T03:18:01ZengWileyInternational Journal of Clinical Practice1742-12412023-01-01202310.1155/2023/7418857Association of Anemia with Parathyroid Hormone Levels and Other Factors in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Cross-Sectional, Real-World Data Study in PakistanHumera Bukhari0Aneeqa Ahmad1Amna Noorin2Aimal Khan3Mehwish Mushtaq4Aamir Naeem5Muhammad Rashid Iqbal6Faiza Naureen7Yasar Shah8Ahad Qayyum9Syed Munib10Amer Azhar11Farman Ullah12Faris Farooq Saeed Khan13Nephrology WardDistrict Headquarters DHQ HospitalPeshawar Institute of Cardiology -M.T. INorthwest General Hospital and Research CenterDepartment of PharmacyConsultant Physician in EndocrinologyConsultant Physician in MedicineDepartment of PharmacyDepartment of PharmacyNephrology WardNephrology WardNephrology WardNephrology WardDepartment of Community Health SciencesEnd-stage renal disease (ESRD) patients are mostly managed with maintenance hemodialysis (MHD). ESRD patients on MHD also present with many complications, such as anemia, hyperparathyroidism, and hepatitis prevalence. This study depicts the real-world scenario of anemia among MHD and end-stage renal disease patients in the Pakistani population. A retrospective, multicentric, and real-world data analytical study was conducted at 4 dialysis centers in Pakistan. The study had a sample size of n = 342 patients on maintenance hemodialysis. The data were gathered from the medical records of patients. Data analysis was performed using STATA Version 16. Statistical significance was gauged at a 0.05 level of significance. According to our results, the mean age of the patients was 45 (±15) years. Most of the patients were male (n = 234, 68.4%), whereas 58.1% of the patients were maintained on twice-weekly hemodialysis. The most commonly reported comorbidities were hypertension and diabetes mellitus. The frequency of dialysis (P < 0.01) and comorbidities (P = 0.009) had a significant association with anemia in MHD patients. The majority of the patients had hyperparathyroidism (52%) with anemia. Upon performing binary logistic regression, multivariate analysis displayed a similar odds value for having anemia in patients with every additional month in the duration of hemodialysis (OR 1.01, P = 0.001), the odds of anemic patients having a positive antihepatitis-C antibody (OR 2.22, P = 0.013), and the odds of having anemia in patients in the age category below 45 years (OR 1.93, P = 0.013). In conclusion, the study results depict that every additional month in the duration of hemodialysis, age (<45 years), and positive anti-HCV antibody status, these variables were more likely to have anemia in our study MHD patients. While in our final multivariate model, no statistically significant association was observed between hyperparathyroidism and anemia.http://dx.doi.org/10.1155/2023/7418857 |
| spellingShingle | Humera Bukhari Aneeqa Ahmad Amna Noorin Aimal Khan Mehwish Mushtaq Aamir Naeem Muhammad Rashid Iqbal Faiza Naureen Yasar Shah Ahad Qayyum Syed Munib Amer Azhar Farman Ullah Faris Farooq Saeed Khan Association of Anemia with Parathyroid Hormone Levels and Other Factors in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Cross-Sectional, Real-World Data Study in Pakistan International Journal of Clinical Practice |
| title | Association of Anemia with Parathyroid Hormone Levels and Other Factors in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Cross-Sectional, Real-World Data Study in Pakistan |
| title_full | Association of Anemia with Parathyroid Hormone Levels and Other Factors in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Cross-Sectional, Real-World Data Study in Pakistan |
| title_fullStr | Association of Anemia with Parathyroid Hormone Levels and Other Factors in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Cross-Sectional, Real-World Data Study in Pakistan |
| title_full_unstemmed | Association of Anemia with Parathyroid Hormone Levels and Other Factors in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Cross-Sectional, Real-World Data Study in Pakistan |
| title_short | Association of Anemia with Parathyroid Hormone Levels and Other Factors in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Cross-Sectional, Real-World Data Study in Pakistan |
| title_sort | association of anemia with parathyroid hormone levels and other factors in patients with end stage renal disease undergoing hemodialysis a cross sectional real world data study in pakistan |
| url | http://dx.doi.org/10.1155/2023/7418857 |
| work_keys_str_mv | AT humerabukhari associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan AT aneeqaahmad associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan AT amnanoorin associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan AT aimalkhan associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan AT mehwishmushtaq associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan AT aamirnaeem associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan AT muhammadrashidiqbal associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan AT faizanaureen associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan AT yasarshah associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan AT ahadqayyum associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan AT syedmunib associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan AT amerazhar associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan AT farmanullah associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan AT farisfarooqsaeedkhan associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan |